NCT01749618

Closing the Gap in Care in Seronegative Inflammatory Arthritis

Closing the Gap in Care in Seronegative Inflammatory Arthritis: From Identification to Implementation of Treating to Target: A Randomized Trial of Feedback, Education, and Behavioural Change

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Pope Research Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.

Conditions

• SpA
• PsA

Interventions

Type	Name	Description
BEHAVIORAL	Education and Feedback	Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.

Timeline

• Start date: 2012-11-01
• Primary completion: 2016-11-01
• Completion: 2016-11-01
• First posted: 2012-12-17
• Last updated: 2017-04-07

Locations

9 sites across 1 country: Canada